15th Jan 2019 4:09 pm |
RNS |
Director/PDMR Shareholding |
15th Jan 2019 3:01 pm |
RNS |
Director/PDMR Shareholding |
15th Jan 2019 2:59 pm |
RNS |
Director/PDMR Shareholding |
15th Jan 2019 2:56 pm |
RNS |
Director/PDMR Shareholding |
15th Jan 2019 2:47 pm |
RNS |
Director/PDMR Shareholding |
15th Jan 2019 12:00 pm |
RNS |
GlaxoSmithKline Extends Tender Offer for TESARO |
11th Jan 2019 4:32 pm |
RNS |
Director/PDMR Shareholding |
11th Jan 2019 4:25 pm |
RNS |
Director/PDMR Shareholding |
2nd Jan 2019 1:45 pm |
RNS |
Total Voting Rights |
20th Dec 2018 5:15 pm |
RNS |
Director/PDMR Shareholding |
19th Dec 2018 7:00 am |
RNS |
GSK and Pfizer create new Consumer Healthcare JV |
14th Dec 2018 1:20 pm |
RNS |
GSK Commences Tender Offer for TESARO Inc. |
12th Dec 2018 4:35 pm |
RNS |
Director/PDMR Shareholding |
4th Dec 2018 10:07 am |
RNS |
Director/PDMR Shareholding |
3rd Dec 2018 2:00 pm |
RNS |
Total Voting Rights |
3rd Dec 2018 12:02 pm |
RNS |
GSK reaches agreement to acquire TESARO |
3rd Dec 2018 8:35 am |
RNS |
GSK to divest Horlicks to Unilever |
30th Nov 2018 4:40 pm |
RNS |
Second Price Monitoring Extn |
30th Nov 2018 4:35 pm |
RNS |
Price Monitoring Extension |
29th Nov 2018 3:40 pm |
RNS |
Director/PDMR Shareholding |
29th Nov 2018 11:45 am |
RNS |
GSK - Update on Review of Horlicks |
27th Nov 2018 3:25 pm |
RNS |
Block listing Interim Review |
22nd Nov 2018 1:02 pm |
RNS |
GSK publishes 2019 Dividend Dates |
12th Nov 2018 2:45 pm |
RNS |
Director/PDMR Shareholding |
12th Nov 2018 9:00 am |
RNS |
Blocklisting Application |
8th Nov 2018 12:43 pm |
RNS |
Director Declaration |
2nd Nov 2018 4:15 pm |
RNS |
Director/PDMR Shareholding |
1st Nov 2018 1:40 pm |
RNS |
Total Voting Rights |
31st Oct 2018 2:15 pm |
RNS |
ViiV positive phIII results with fostemsavir |
31st Oct 2018 12:07 pm |
RNS |
Second Price Monitoring Extn |
31st Oct 2018 12:02 pm |
RNS |
Price Monitoring Extension |
31st Oct 2018 12:00 pm |
RNS |
3rd Quarter Results |
30th Oct 2018 2:30 pm |
RNS |
ViiV: positive data for long-acting injectable |
29th Oct 2018 10:00 am |
RNS |
ViiV - three-year data for long-acting injectable |
18th Oct 2018 4:00 pm |
RNS |
ViiV submits HIV 2DR regulatory application to FDA |
18th Oct 2018 9:34 am |
RNS |
Director/PDMR Shareholding |
17th Oct 2018 5:56 pm |
RNS |
Director/PDMR Shareholding |
17th Oct 2018 5:50 pm |
RNS |
Director/PDMR Shareholding |
17th Oct 2018 11:30 am |
RNS |
Director/PDMR Shareholding |
16th Oct 2018 4:53 pm |
RNS |
Director/PDMR Shareholding |